Literature DB >> 7944529

Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.

P H Verkerk1, F J van Spronsen, G P Smit, R C Sengers.   

Abstract

OBJECTIVE: To assess whether physical growth is affected in early treated Dutch patients with phenylketonuria (PKU).
METHODS: The birth weights of all 137 early detected patients with PKU born in the period from 1974 to 1988 in the Netherlands were compared with reference values. Height, head circumference, and weight were measured at the age at which treatment started (commonly about 2-3 weeks), at 6 months of age, and yearly from the child's first birthday up to the age of 10 years. These measurements were compared with reference values.
RESULTS: The adjusted birth weight in patients with PKU was 141 g (95% confidence interval (CI) 66 to 216 g) less than Dutch reference values by Kloosterman and 103 g (95% CI 9 to 196 g) less compared with the birth weight of another reference group. At the age at which treatment started, z scores of patients for height by age were -0.23 (95% CI -0.44 to -0.02) and z scores for head circumference by the age were -0.25 (95% CI -0.44 to -0.06). From the age at which treatment started up to the age of 3 years z scores for height by age further decreased to -0.74 (95% confidence interval -0.93 to -0.56), after which no additional decrease occurred. In contrast, z scores for head circumference increased from -0.25 at the first visit to 0.08 (95% CI -0.14 to 0.30) at the age of 1 year, after which they remained close to zero. Weight by height was close to the expected centiles for all ages.
CONCLUSION: Patients with PKU are growth retarded at birth and have smaller head circumferences than the normal population. In Dutch patients further growth retardation occurs in the first three years of life.

Entities:  

Mesh:

Year:  1994        PMID: 7944529      PMCID: PMC1029938          DOI: 10.1136/adc.71.2.114

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Prevalence of congenital heart disease in patients with phenylketonuria.

Authors:  P H Verkerk; F J van Spronsen; G P Smit; M C Cornel; J R Kuipers; S P Verloove-Vanhorick
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

2.  [Are earlier birth weights different from current ones?].

Authors:  F J Voorhorst; J I Puyenbroek; E A Robertson; P D Bezemer; P H Kurver
Journal:  Ned Tijdschr Geneeskd       Date:  1990-05-19

3.  [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].

Authors:  H P Schwarz; C Plüss; H Triaca; B Schütz; R Kaufmann; R Scherz; C Bachmann; K Zuppinger
Journal:  Schweiz Med Wochenschr       Date:  1988-01-23

4.  Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.

Authors:  C J De Groot; F A Hommes
Journal:  Enzyme       Date:  1982

5.  Phenylalanine deficiency syndrome.

Authors:  B M Rouse
Journal:  J Pediatr       Date:  1966-08       Impact factor: 4.406

6.  [15 years of national screening for phenylketonuria in The Netherlands; 4th Report of the National Commission for Management of Phenylketonuria].

Authors:  P H Verkerk; G J Vaandrager; R C Sengers
Journal:  Ned Tijdschr Geneeskd       Date:  1990-12-29

7.  Physical growth of children treated for phenylketonuria.

Authors:  M A McBurnie; R A Kronmal; V E Schuett; R Koch; C G Azeng
Journal:  Ann Hum Biol       Date:  1991 Jul-Aug       Impact factor: 1.533

8.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

9.  Excess weight among children with phenylketonuria.

Authors:  J E White; R A Kronmal; P B Acosta
Journal:  J Am Coll Nutr       Date:  1982       Impact factor: 3.169

10.  [10 years' national screening study of the incidence of phenylketonuria in the Netherlands; 3d report of the National Advisory Phenylketonuria Commission].

Authors:  W J Meijer
Journal:  Ned Tijdschr Geneeskd       Date:  1985-01-12
View more
  23 in total

1.  New insights in growth of phenylketonuric patients.

Authors:  María L Couce; Ipek Guler; Andrés Anca-Couce; Marta Lojo; Alicia Mirás; Rosaura Leis; Alejandro Pérez-Muñuzuri; José M Fraga; Francisco Gude
Journal:  Eur J Pediatr       Date:  2014-11-01       Impact factor: 3.183

2.  The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.

Authors:  M Hoeksma; M Van Rijn; P H Verkerk; A M Bosch; M F Mulder; J B C de Klerk; T J de Koning; E Rubio-Gozalbo; M de Vries; P J J Sauer; F J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Authors:  S Yannicelli; D M Medeiros
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  Does a single plasma phenylalanine predict quality of control in phenylketonuria?

Authors:  A MacDonald; G W Rylance; D Asplin; S K Hall; I W Booth
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

5.  Birth weight in phenylketonuria.

Authors:  L I Woolf; D J Crockett
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

6.  Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO Expert Consultation.

Authors:  G Krauch; E Müller; A Anninos; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Recommendations for protein and energy intakes by patients with phenylketonuria.

Authors:  P B Acosta
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  Protein substitutes for PKU: what's new?

Authors:  A Macdonald; A Daly; P Davies; D Asplin; S K Hall; G Rylance; A Chakrapani
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  No reduction in birth weight in phenylketonuria.

Authors:  S L Tillotson; P M Costello; I Smith
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

10.  Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.

Authors:  D Dobbelaere; L Michaud; A Debrabander; S Vanderbecken; F Gottrand; D Turck; J P Farriaux
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.